Autosomal dominant partial epilepsy with auditory features
Alternate names[edit | edit source]
ADLTE; ADPEAF; Autosomal dominant lateral temporal lobe epilepsy; ETL1
Definition[edit | edit source]
Autosomal dominant partial epilepsy with auditory features (ADPEAF) is a rare form of epilepsy, a condition that is characterized by recurrent seizures.
Epidemiology[edit | edit source]
This condition appears to be uncommon, although its prevalence is unknown.
Cause[edit | edit source]
- ADPEAF is caused by changes (mutations) in the LGI1 or RELN gene.
- This gene provides instructions for making a protein called Lgi1 or epitempin, which is found primarily in nerve cells (neurons) in the brain.
- Although researchers have proposed several functions for this protein, its precise role in the brain remains uncertain.
Gene mutations[edit | edit source]
- Mutations in the LGI1 gene likely disrupt the function of epitempin.
- It is unclear how the altered protein leads to seizure activity in the brain.
- LGI1 mutations have been identified in about half of all families diagnosed with ADPEAF.
- In the remaining families, the cause of the condition is unknown.
- Researchers are searching for other genetic changes that may underlie the condition.
Inheritance[edit | edit source]
This condition is inherited in an autosomal dominant manner.
Onset[edit | edit source]
Signs and symptoms of the condition generally begin in adolescence or early adulthood.
Signs and symptoms[edit | edit source]
- In ADPEAF, specifically, most affected people experience secondary generalized seizures and partial seizures, some of which are associated with sound-related symptoms (such as buzzing, humming, or ringing) and/or receptive aphasia (inability to understand written or spoken words).
- Less commonly, seizures may cause visual hallucinations, a disturbance in the sense of smell, vertigo, or other symptoms affecting the senses.
Diagnosis[edit | edit source]
- The clinical diagnosis of ADEAF is established with characteristic clinical features, normal brain imaging (MRI or CT), and family history consistent with autosomal dominant inheritance.[1]
- Identification of a heterozygous pathogenic variant in LGI1, MICAL1, or RELN by molecular genetic testing establishes the diagnosis.
Treatment[edit | edit source]
The seizures associated with ADPEAF are typically well controlled with medications that are used to treat epilepsy (called antiepileptic drugs).
References[edit | edit source]
- ↑ Michelucci R, Nobile C. Autosomal Dominant Epilepsy with Auditory Features. 2007 Apr 20 [Updated 2019 Jan 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1537/
NIH genetic and rare disease info[edit source]
Autosomal dominant partial epilepsy with auditory features is a rare disease.
Autosomal dominant partial epilepsy with auditory features Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD